Skip to main content

droxidopa

Generic: DROXIDOPA·Brand: DROXIDOPA, NORTHERA, Northera

droxidopa: 1 clinical trial tracked.

droxidopa evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about droxidopa, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (1)

Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease: Double-blind Placebo-controlled Randomized Crossover Clinical Trial.

NCT07398508Registry updated 2026-02-10·Phase 1
Recruiting

Primary endpoint: Incidence of SAEs

InterventionalRandomizedquadruple6 targetStarted 2026-06Completion 2030-061 site · United StatesStephen G. Kaler